Other small states vs Switzerland: Access to anti-retroviral drugs, male
Other small states
74.4%
in 2022
Switzerland
90.0%
in 2023
Other small states rank
12th
Switzerland rank
13th
Access to anti-retroviral drugs, male over time
- Other small states
- Switzerland
How they compare
Switzerland currently reports 90.0% against 74.4% in Other small states, a difference of 15.6%.
That makes Switzerland's figure about 1.2 times Other small states's.
Across all 19 years both countries report, Switzerland has been ahead every year.
Other small states ranks 12th and Switzerland ranks 13th of 19 groups.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Other small states | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.9% | 47.5% | 41.6% | Switzerland |
| 2010s | 46.1% | 79.2% | 33.1% | Switzerland |
| 2020s | 73.1% | 90.3% | 17.3% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Other small states or Switzerland?
- Switzerland, at 90.0% against 74.4% in Other small states as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Other small states and Switzerland?
- 15.6%, with Switzerland ahead.
- How many years of comparable data are there for Other small states and Switzerland?
- 19 years are reported by both, from 2000 to 2022.
- How do Other small states and Switzerland rank globally for access to anti-retroviral drugs, male?
- Other small states ranks 12th and Switzerland ranks 13th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.